Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Spain Introduces ‘Vaccine Passports’

Spain introduced a vaccination passport to hopefully revive…
Read more

Biden Ignores China’s Uyghur Genocide

Joe Biden blatantly disregarded China's Uyghur genocide after…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Netanyahu speaks with Biden

After nearly one month in office, Joe Biden made the efforts…
Read more